SKI Market

Indian Indices

Nifty

22,466.10 62.25
(0.28%)

Sensex

73,917.03 253.31
( 0.34%)

Bank Nifty

48,115.65 138.60
( 0.29%)

Nifty IT

33,381.85 -286.60
( -0.85%)

Global Indices

Nasdaq

16,698.32 -44.07
(-0.26%)

Dow Jones

39,869.38 -38.62
(-0.10%)

Hang Seng

19,553.61 177.08
(0.91%)

Nikkei 225

38,787.38 -132.88
(-0.34%)

Forex

USD-INR

83.46 -0.04
(-0.05%)

EUR-INR

90.54 0.34
(0.38%)

GBP-INR

105.44 0.50
(0.48%)

JPY-INR

0.54 0.00
(0.51%)

YOU ARE HERE :
HOME
Markets
Equity
Profit and Loss

EQUITY - MARKET SCREENER

Zim Laboratories Ltd

Industry : Pharmaceuticals - Indian - Formulations

BSE Code

ISIN Demat

Book Value()

541400

INE518E01015

47.6042974

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

ZIMLAB

33.01

553.28

EPS(TTM)

Face Value()

Div & Yield %

3.44

Particulars(INCOME)	Mar 2023 ( Cr)	Mar 2022 ( Cr)	Mar 2021 ( Cr)	Mar 2020 ( Cr)	Mar 2019 ( Cr)	Mar 2018 ( Cr)
Sales Turnover	396.53	329.49	303.63	274.32	331.72	273.36
Excise Duty	0.00	0.00	0.00	0.00	0.00	1.47
Net Sales	396.53	329.49	303.63	274.32	331.72	271.89
Other Income	6.43	4.51	2.45	4.66	2.05	9.29
Stock Adjustments	-16.46	9.67	1.11	6.40	0.12	0.90
Total Income	386.50	343.67	307.19	285.38	333.89	282.08
EXPENDITURE :
Raw Materials	182.37	170.02	159.74	149.54	159.63	141.79
Power & Fuel Cost	11.09	9.14	7.04	7.47	7.19	5.75
Employee Cost	46.47	38.63	34.48	34.58	48.14	40.80
Other Manufacturing Expenses	27.30	23.76	19.02	22.37	6.66	4.68
Selling & Administrative Expenses	55.69	54.44	43.70	40.96	63.26	42.14
Miscellaneous Expenses	5.95	5.24	9.12	6.01	4.54	3.67
Less : Pre-operative Expenses Capitalised	0.00	0.00	0.00	0.00	0.00	0.00
Total Expenditure	328.87	301.23	273.11	260.94	289.42	238.84
Operating Profit	57.63	42.44	34.08	24.43	44.47	43.24
Interest	5.58	8.31	10.89	12.65	10.59	9.34
Gross Profit	52.05	34.13	23.19	11.78	33.88	33.90
Depreciation	16.13	14.84	14.61	13.27	11.14	9.79
Profit Before Tax	35.92	19.29	8.58	-1.49	22.74	24.11
Tax	6.28	3.40	0.02	-0.12	4.90	-1.26
Fringe Benefit tax	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax	4.63	2.88	2.95	-3.10	1.82	7.08
Reported Net Profit	25.01	13.01	5.62	1.74	16.01	18.29
Extraordinary Items	0.00	0.00	-3.39	-0.01	-0.29	4.06
Adjusted Net Profit	25.01	13.01	9.01	1.75	16.30	14.23
Adjustment below Net Profit	0.00	0.00	0.00	0.49	0.00	0.00
P & L Balance brought forward	111.81	98.76	93.52	92.54	77.92	60.72
Statutory Appropriations	0.00	0.00	0.00	0.00	0.00	0.00
Appropriations	0.46	-0.05	0.39	1.24	1.39	1.09
P & L Balance carried down	136.36	111.81	98.76	93.52	92.54	77.92
Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Preference Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Equity Dividend %	0.00	0.00	0.00	0.00	5.00	10.00
Dividend Per Share(Rs)	0.00	0.00	0.00	0.00	0.50	1.00
Earnings Per Share-Unit Curr	5.13	8.01	3.46	1.08	9.93	22.69
Earnings Per Share(Adj)-Unit Curr	5.13	2.67	1.15	0.36	3.31	22.69
Book Value-Unit Curr	39.85	104.73	96.69	93.79	93.81	168.70
Book Value(Adj)-Unit Curr	39.85	34.91	32.23	31.26	31.27	168.70

22,466.10 62.25 (0.28%)

73,917.03 253.31 ( 0.34%)

48,115.65 138.60 ( 0.29%)

33,381.85 -286.60 ( -0.85%)

16,698.32 -44.07 (-0.26%)

39,869.38 -38.62 (-0.10%)

19,553.61 177.08 (0.91%)

38,787.38 -132.88 (-0.34%)

83.46 -0.04 (-0.05%)

90.54 0.34 (0.38%)

105.44 0.50 (0.48%)

0.54 0.00 (0.51%)